The mandates cover:
1) The purchase of not more than 4 300 000 series A shares, whereof a maximum 3 420 000 may be transferred to personnel stock option holders under the Performance Stock Option Plan 2011.
2) The purchase of not more than 70 000 series A shares, later to be sold on the market in connection with payment to Board members who have opted to receive synthetic shares as part of their board fee.
3) The sale of not more than 70 000 series A shares to cover costs related to previously issued synthetic shares to Board members.
4) The sale of maximum 4 700 000 series A shares and maximum 1 500 000 series B shares currently held by the company, for the purpose of covering costs of fulfilling obligations related to the performance stock option plans 2006-2009.
Repurchases and sales are subject to market conditions, regulatory restrictions and the capital structure at any given time.
The number of issued shares is presently 1 229 613 104, whereof 839 394 096 series A shares and 390 219 008 series B shares. The company holds 15 034 079 series A shares and 1 590 873 series B shares.
For further information please contact:
Daniel Frykholm, Media Relations Manager
46 (0)8 743 8060 or 46 (0)70 865 8060
Atlas Copco discloses the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act.
